HEADER TRANSFERASE 14-DEC-18 6Q8K TITLE CLK1 WITH BOUND PYRIDOQUINAZOLINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN KINASE CLK1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CDC-LIKE KINASE 1; COMPND 5 EC: 2.7.12.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CLK1, CLK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CLK1, DUAL SPECIFITY PROTEIN KINASE CLK1, INHIBITOR, KINASE, KEYWDS 2 STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, KEYWDS 3 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.SCHROEDER,H.TAZARKI,W.ZEINYEH,Y.J.ESVAN,J.KHIARI,B.JOESSELIN, AUTHOR 2 S.BACH,S.RUCHAUD,F.ANIZON,F.GIRAUD,P.MOREAU,C.H.ARROWSMITH, AUTHOR 3 A.M.EDWARDS,C.BOUNTRA,S.KNAPP,STRUCTURAL GENOMICS CONSORTIUM (SGC) REVDAT 3 15-MAY-24 6Q8K 1 REMARK REVDAT 2 27-FEB-19 6Q8K 1 AUTHOR REVDAT 1 20-FEB-19 6Q8K 0 JRNL AUTH H.TAZARKI,W.ZEINYEH,Y.J.ESVAN,S.KNAPP,D.CHATTERJEE, JRNL AUTH 2 M.SCHRODER,A.C.JOERGER,J.KHIARI,B.JOSSELIN,B.BARATTE,S.BACH, JRNL AUTH 3 S.RUCHAUD,F.ANIZON,F.GIRAUD,P.MOREAU JRNL TITL NEW PYRIDO[3,4-G]QUINAZOLINE DERIVATIVES AS CLK1 AND DYRK1A JRNL TITL 2 INHIBITORS: SYNTHESIS, BIOLOGICAL EVALUATION AND BINDING JRNL TITL 3 MODE ANALYSIS. JRNL REF EUR J MED CHEM V. 166 304 2019 JRNL REFN ISSN 1768-3254 JRNL PMID 30731399 JRNL DOI 10.1016/J.EJMECH.2019.01.052 REMARK 2 REMARK 2 RESOLUTION. 2.29 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0238 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.29 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 64.25 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 15830 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 808 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.29 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.35 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1165 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.99 REMARK 3 BIN R VALUE (WORKING SET) : 0.2400 REMARK 3 BIN FREE R VALUE SET COUNT : 58 REMARK 3 BIN FREE R VALUE : 0.2650 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2728 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 29 REMARK 3 SOLVENT ATOMS : 129 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.14 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.13000 REMARK 3 B22 (A**2) : -0.57000 REMARK 3 B33 (A**2) : -0.52000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.15000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.369 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.261 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.192 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 15.207 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.942 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.889 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2862 ; 0.014 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2619 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3874 ; 1.753 ; 1.636 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6069 ; 1.333 ; 1.600 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 339 ; 7.826 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 149 ;34.528 ;22.148 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 489 ;15.224 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;23.158 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 365 ; 0.084 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3330 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 622 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1355 ; 1.008 ; 1.639 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1355 ; 1.008 ; 1.639 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1690 ; 1.689 ; 2.453 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1691 ; 1.688 ; 2.453 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1506 ; 1.131 ; 1.788 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1507 ; 1.131 ; 1.789 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2182 ; 1.858 ; 2.631 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 3158 ; 4.300 ;19.355 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 3135 ; 4.270 ;19.215 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 147 A 345 REMARK 3 ORIGIN FOR THE GROUP (A): -13.1876 9.6182 18.3982 REMARK 3 T TENSOR REMARK 3 T11: 0.1341 T22: 0.0582 REMARK 3 T33: 0.0576 T12: 0.0174 REMARK 3 T13: 0.0545 T23: 0.0460 REMARK 3 L TENSOR REMARK 3 L11: 3.3069 L22: 2.5885 REMARK 3 L33: 1.0190 L12: -0.8508 REMARK 3 L13: 1.2931 L23: -0.2157 REMARK 3 S TENSOR REMARK 3 S11: 0.1349 S12: 0.3329 S13: 0.3204 REMARK 3 S21: -0.3310 S22: -0.2259 S23: -0.1625 REMARK 3 S31: -0.1553 S32: 0.1899 S33: 0.0910 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 346 A 484 REMARK 3 ORIGIN FOR THE GROUP (A): 9.7167 1.6632 25.4399 REMARK 3 T TENSOR REMARK 3 T11: 0.0938 T22: 0.1183 REMARK 3 T33: 0.2691 T12: -0.0262 REMARK 3 T13: 0.0447 T23: -0.0107 REMARK 3 L TENSOR REMARK 3 L11: 4.8745 L22: 2.3526 REMARK 3 L33: 4.5526 L12: -0.2896 REMARK 3 L13: -2.0495 L23: 2.0559 REMARK 3 S TENSOR REMARK 3 S11: 0.2254 S12: -0.3763 S13: 0.1278 REMARK 3 S21: -0.1622 S22: 0.1860 S23: -0.7431 REMARK 3 S31: -0.4081 S32: 0.6421 S33: -0.4113 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6Q8K COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-DEC-18. REMARK 100 THE DEPOSITION ID IS D_1200013455. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-OCT-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9184 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16639 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.290 REMARK 200 RESOLUTION RANGE LOW (A) : 64.250 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : 0.08200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.29 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 255 PEG 6000. 0.1 M BICINE PH 9.0, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z+1/2 REMARK 290 4555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 21.67332 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.15000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 40.57121 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 21.67332 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 32.15000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 40.57121 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 190 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16240 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 146 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 263 CG OD1 OD2 REMARK 470 LYS A 274 CG CD CE NZ REMARK 470 ARG A 343 CG CD NE CZ NH1 NH2 REMARK 470 HIS A 344 CG ND1 CD2 CE1 NE2 REMARK 470 HIS A 382 CG ND1 CD2 CE1 NE2 REMARK 470 ARG A 393 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 405 CG CD CE NZ REMARK 470 ARG A 407 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 416 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 420 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 160 -33.61 -152.31 REMARK 500 GLU A 169 -158.73 -118.27 REMARK 500 ASN A 195 46.92 -79.41 REMARK 500 THR A 287 -18.18 80.91 REMARK 500 ASP A 300 68.02 -101.14 REMARK 500 ASP A 325 94.14 68.96 REMARK 500 SER A 341 154.49 83.98 REMARK 500 SER A 357 -147.25 -165.58 REMARK 500 PHE A 379 60.20 -117.63 REMARK 500 LYS A 408 52.81 -68.44 REMARK 500 HIS A 414 -126.45 36.01 REMARK 500 ASP A 420 91.15 -59.99 REMARK 500 SER A 483 23.88 -156.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FG9 A 502 DBREF 6Q8K A 148 484 UNP P49759 CLK1_HUMAN 148 484 SEQADV 6Q8K SER A 146 UNP P49759 EXPRESSION TAG SEQADV 6Q8K MET A 147 UNP P49759 EXPRESSION TAG SEQADV 6Q8K ALA A 432 UNP P49759 ARG 432 CONFLICT SEQRES 1 A 339 SER MET HIS LEU ILE CYS GLN SER GLY ASP VAL LEU SER SEQRES 2 A 339 ALA ARG TYR GLU ILE VAL ASP THR LEU GLY GLU GLY ALA SEQRES 3 A 339 PHE GLY LYS VAL VAL GLU CYS ILE ASP HIS LYS ALA GLY SEQRES 4 A 339 GLY ARG HIS VAL ALA VAL LYS ILE VAL LYS ASN VAL ASP SEQRES 5 A 339 ARG TYR CYS GLU ALA ALA ARG SER GLU ILE GLN VAL LEU SEQRES 6 A 339 GLU HIS LEU ASN THR THR ASP PRO ASN SER THR PHE ARG SEQRES 7 A 339 CYS VAL GLN MET LEU GLU TRP PHE GLU HIS HIS GLY HIS SEQRES 8 A 339 ILE CYS ILE VAL PHE GLU LEU LEU GLY LEU SER THR TYR SEQRES 9 A 339 ASP PHE ILE LYS GLU ASN GLY PHE LEU PRO PHE ARG LEU SEQRES 10 A 339 ASP HIS ILE ARG LYS MET ALA TYR GLN ILE CYS LYS SER SEQRES 11 A 339 VAL ASN PHE LEU HIS SER ASN LYS LEU THR HIS THR ASP SEQRES 12 A 339 LEU LYS PRO GLU ASN ILE LEU PHE VAL GLN SER ASP TYR SEQRES 13 A 339 THR GLU ALA TYR ASN PRO LYS ILE LYS ARG ASP GLU ARG SEQRES 14 A 339 THR LEU ILE ASN PRO ASP ILE LYS VAL VAL ASP PHE GLY SEQRES 15 A 339 SER ALA THR TYR ASP ASP GLU HIS HIS SER THR LEU VAL SEQRES 16 A 339 SER THR ARG HIS TYR ARG ALA PRO GLU VAL ILE LEU ALA SEQRES 17 A 339 LEU GLY TRP SER GLN PRO CYS ASP VAL TRP SER ILE GLY SEQRES 18 A 339 CYS ILE LEU ILE GLU TYR TYR LEU GLY PHE THR VAL PHE SEQRES 19 A 339 PRO THR HIS ASP SER LYS GLU HIS LEU ALA MET MET GLU SEQRES 20 A 339 ARG ILE LEU GLY PRO LEU PRO LYS HIS MET ILE GLN LYS SEQRES 21 A 339 THR ARG LYS ARG LYS TYR PHE HIS HIS ASP ARG LEU ASP SEQRES 22 A 339 TRP ASP GLU HIS SER SER ALA GLY ARG TYR VAL SER ARG SEQRES 23 A 339 ALA CYS LYS PRO LEU LYS GLU PHE MET LEU SER GLN ASP SEQRES 24 A 339 VAL GLU HIS GLU ARG LEU PHE ASP LEU ILE GLN LYS MET SEQRES 25 A 339 LEU GLU TYR ASP PRO ALA LYS ARG ILE THR LEU ARG GLU SEQRES 26 A 339 ALA LEU LYS HIS PRO PHE PHE ASP LEU LEU LYS LYS SER SEQRES 27 A 339 ILE HET EDO A 501 4 HET FG9 A 502 50 HETNAM EDO 1,2-ETHANEDIOL HETNAM FG9 ~{N}2-(3-MORPHOLIN-4-YLPROPYL)PYRIDO[3,4-G]QUINAZOLINE- HETNAM 2 FG9 2,10-DIAMINE HETSYN EDO ETHYLENE GLYCOL FORMUL 2 EDO C2 H6 O2 FORMUL 3 FG9 C18 H22 N6 O FORMUL 4 HOH *129(H2 O) HELIX 1 AA1 MET A 147 CYS A 151 5 5 HELIX 2 AA2 VAL A 196 ASP A 217 1 22 HELIX 3 AA3 SER A 247 ASN A 255 1 9 HELIX 4 AA4 ARG A 261 ASN A 282 1 22 HELIX 5 AA5 LYS A 290 GLU A 292 5 3 HELIX 6 AA6 PRO A 307 LYS A 310 5 4 HELIX 7 AA7 THR A 342 ARG A 346 5 5 HELIX 8 AA8 ALA A 347 LEU A 352 1 6 HELIX 9 AA9 GLN A 358 GLY A 375 1 18 HELIX 10 AB1 ASP A 383 GLY A 396 1 14 HELIX 11 AB2 PRO A 399 THR A 406 1 8 HELIX 12 AB3 LYS A 408 LYS A 410 5 3 HELIX 13 AB4 SER A 423 CYS A 433 1 11 HELIX 14 AB5 PRO A 435 MET A 440 5 6 HELIX 15 AB6 ASP A 444 LEU A 458 1 15 HELIX 16 AB7 THR A 467 LEU A 472 1 6 HELIX 17 AB8 LYS A 473 LYS A 482 5 10 SHEET 1 AA1 6 VAL A 156 LEU A 157 0 SHEET 2 AA1 6 TYR A 161 GLY A 168 -1 O TYR A 161 N LEU A 157 SHEET 3 AA1 6 GLY A 173 ASP A 180 -1 O VAL A 175 N GLY A 168 SHEET 4 AA1 6 HIS A 187 VAL A 193 -1 O ILE A 192 N LYS A 174 SHEET 5 AA1 6 HIS A 236 GLU A 242 -1 O PHE A 241 N ALA A 189 SHEET 6 AA1 6 MET A 227 HIS A 233 -1 N PHE A 231 O CYS A 238 SHEET 1 AA2 2 LEU A 284 THR A 285 0 SHEET 2 AA2 2 THR A 330 TYR A 331 -1 O THR A 330 N THR A 285 SHEET 1 AA3 2 ILE A 294 PHE A 296 0 SHEET 2 AA3 2 ILE A 321 VAL A 323 -1 O LYS A 322 N LEU A 295 SHEET 1 AA4 2 TYR A 301 ASN A 306 0 SHEET 2 AA4 2 ARG A 311 LEU A 316 -1 O THR A 315 N THR A 302 SHEET 1 AA5 2 PHE A 412 HIS A 413 0 SHEET 2 AA5 2 ARG A 416 LEU A 417 -1 O ARG A 416 N HIS A 413 SITE 1 AC1 5 LYS A 456 ILE A 466 GLU A 470 HOH A 604 SITE 2 AC1 5 HOH A 632 SITE 1 AC2 16 LEU A 167 PHE A 172 VAL A 175 ALA A 189 SITE 2 AC2 16 LYS A 191 PHE A 241 GLU A 242 LEU A 243 SITE 3 AC2 16 LEU A 244 GLY A 245 LEU A 246 LYS A 290 SITE 4 AC2 16 ASN A 293 LEU A 295 ASP A 325 HOH A 625 CRYST1 72.848 64.300 86.339 90.00 109.98 90.00 I 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013727 0.000000 0.004990 0.00000 SCALE2 0.000000 0.015552 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012324 0.00000